Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device
NCT: NCT03429582 · COMPLETED
Brief Summary
The purpose of this academic-industrial partnership will be to compare two thermoablation modalities using devices adapted to low and middle income countries (LMICs) to traditional CO2-based cryotherapy for the treatment of cervical precancer. The investigators will investigate whether the cure rates of cervical intraepithelial neoplasia 2 and more severe diagnoses (CIN2+) with these devices are non-inferior compared to that of conventional cryotherapy. The results of this study will affect other research areas by serving as a springboard to exploring treatment alternatives that are amenable to low-resource settings and thus will reach the most vulnerable populations.
Frequently Asked Questions
What is Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device?
Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device is a clinical trial registered under NCT03429582. Current status: COMPLETED.
What is the status of NCT03429582?
The current status of NCT03429582 (Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device) is: COMPLETED.
When did Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device start?
Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device started on 2020-10-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.